Literature DB >> 33898343

Exhaustion and senescence of CD4 and CD8 T cells that express co-stimulatory molecules CD27 and CD28 in subjects that acquired HIV by drug use or by sexual route.

Leontina Bănică1, Ovidiu Vlaicu1, Raluca Jipa2, Adrian Abagiu2, Ionelia Nicolae3, Emil Neaga1, Dan Oţelea4, Simona Paraschiv5.   

Abstract

INTRODUCTION: The human immunodeficiency virus (HIV) infection leads to immune activation, senescence and exhaustion of T cells. Co-stimulatory molecules play important roles in controlling these processes. The CD28 signaling triggers efficient T cell activation, while CD27 provides survival signals to CD28- T cells. Loss of these molecules was associated with senescent phenotype and resistance to checkpoint inhibitors.Romania has faced an HIV outbreak among people who inject drugs (PWID), most of them chronically infected with hepatitis C virus (HCV). HIV/HCV co-infection was associated with increased immune activation and rapid disease progression.
METHODS: We evaluated by flow cytometry the expression of CD27, CD28, CD38, HLA-DR, CD57 and PD-1 on CD4 and CD8 T cells from 34 subjected infected with HIV (22 PWID and 12 people who acquired HIV by sexual route - PWHS) and 18 HIV-negative individuals (controls).
RESULTS: We found that as compared to controls, HIV patients, regardless of infection route, have high percentages of intermediately differentiated (CD27+CD28-) and low percentages of less differentiated (CD27+CD28+) CD8 T cells. Significantly higher levels of CD8+CD27+CD28- T cells were found in PWHS than in PWID. A lower percentage of intermediately and highly differentiated (CD27-CD28-) CD8 T cells express CD57 in people living with HIV (PLWH) than in controls. Increased levels of less and intermediately differentiated CD4 and CD8 T cells expressing PD-1 were identified in PLWH, especially in PWID; these directly correlated with HIV viral load and T cell activation and negatively correlated with CD4 counts.
CONCLUSIONS: Our data show that induction of PD-1 on T cells expressing co-stimulatory molecules CD27 and/or CD28 might contribute to poor control of HIV infection and to immune activation. GERMS.

Entities:  

Keywords:  HIV/HCV co-infection; PWID; T cell exhaustion; co-stimulatory molecules

Year:  2021        PMID: 33898343      PMCID: PMC8057851          DOI: 10.18683/germs.2021.1242

Source DB:  PubMed          Journal:  Germs        ISSN: 2248-2997


  25 in total

1.  Recent HIV-1 Outbreak Among Intravenous Drug Users in Romania: Evidence for Cocirculation of CRF14_BG and Subtype F1 Strains.

Authors:  Iulia Niculescu; Simona Paraschiv; Dimitrios Paraskevis; Adrian Abagiu; Ionelia Batan; Leontina Banica; Dan Otelea
Journal:  AIDS Res Hum Retroviruses       Date:  2014-11-04       Impact factor: 2.205

2.  Functional and phenotypic characterization of CD57+CD4+ T cells and their association with HIV-1-induced T cell dysfunction.

Authors:  Brent E Palmer; Naomi Blyveis; Andrew P Fontenot; Cara C Wilson
Journal:  J Immunol       Date:  2005-12-15       Impact factor: 5.422

3.  Altered T cell differentiation associated with loss of CD27 and CD28 in HIV infected Indian individuals.

Authors:  Kamalika Mojumdar; Madhu Vajpayee; Neeraj Kumar Chauhan; Alpana Singh; Ravinder Singh; Sravya Kurapati
Journal:  Cytometry B Clin Cytom       Date:  2011-06-21       Impact factor: 3.058

4.  Low proportions of CD28- CD8+ T cells expressing CD57 can be reversed by early ART initiation and predict mortality in treated HIV infection.

Authors:  Sulggi A Lee; Elizabeth Sinclair; Vivek Jain; Yong Huang; Lorrie Epling; Mark Van Natta; Curtis L Meinert; Jeffrey N Martin; Joseph M McCune; Steven G Deeks; Michael M Lederman; Frederick M Hecht; Peter W Hunt
Journal:  J Infect Dis       Date:  2014-02-28       Impact factor: 5.226

Review 5.  T cell replicative senescence in human aging.

Authors:  Jennifer P Chou; Rita B Effros
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

6.  Premature aging of T cells is associated with faster HIV-1 disease progression.

Authors:  Weiwei Cao; Beth D Jamieson; Lance E Hultin; Patricia M Hultin; Rita B Effros; Roger Detels
Journal:  J Acquir Immune Defic Syndr       Date:  2009-02-01       Impact factor: 3.731

Review 7.  Mechanisms of Resistance to Immune Checkpoint Blockade.

Authors:  David Liu; Russell W Jenkins; Ryan J Sullivan
Journal:  Am J Clin Dermatol       Date:  2019-02       Impact factor: 7.403

8.  PD-1 blockade potentiates HIV latency reversal ex vivo in CD4+ T cells from ART-suppressed individuals.

Authors:  Rémi Fromentin; Sandrina DaFonseca; Cecilia T Costiniuk; Mohamed El-Far; Francesco Andrea Procopio; Frederick M Hecht; Rebecca Hoh; Steven G Deeks; Daria J Hazuda; Sharon R Lewin; Jean-Pierre Routy; Rafick-Pierre Sékaly; Nicolas Chomont
Journal:  Nat Commun       Date:  2019-02-18       Impact factor: 14.919

Review 9.  Immune Activation, Inflammation, and Non-AIDS Co-Morbidities in HIV-Infected Patients under Long-Term ART.

Authors:  Sonia Zicari; Libera Sessa; Nicola Cotugno; Alessandra Ruggiero; Elena Morrocchi; Carlo Concato; Salvatore Rocca; Paola Zangari; Emma C Manno; Paolo Palma
Journal:  Viruses       Date:  2019-02-27       Impact factor: 5.048

10.  CD27 promotes survival of activated T cells and complements CD28 in generation and establishment of the effector T cell pool.

Authors:  Jenny Hendriks; Yanling Xiao; Jannie Borst
Journal:  J Exp Med       Date:  2003-10-27       Impact factor: 14.307

View more
  1 in total

1.  Changes of T lymphocyte subpopulations and their roles in predicting the risk of Parkinson's disease.

Authors:  Yijing He; Kangwen Peng; Ruoyu Li; Zhuoyu Zhang; Lizhen Pan; Tianyu Zhang; Ao Lin; Ronghua Hong; Zhiyu Nie; Qiang Guan; Lingjing Jin
Journal:  J Neurol       Date:  2022-05-24       Impact factor: 6.682

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.